S1 Guidelines for the Kaposi Sarcoma

Stefan Eßer(Essen University Hospital), Stephan Grabbe(Goethe University Frankfurt), Mark Oette, Thomas F. Schulz(Medizinische Hochschule Hannover), Anja Potthoff(Ruhr University Bochum), Helmut Schöfer(Goethe University Frankfurt), Franz Mosthaf, Doris Helbig(University Hospital Cologne), Selma Ugurel(Klinikum Bielefeld), Jürgen C. Becker(Düsseldorf University Hospital), Mirjana Ziemer(University Medical Center), Alexander Kreuter(HELIOS St. Elisabeth Klinik Oberhausen), Ulrike Leiter(University of Tübingen), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Johannes Claßen(St. Vincentius-Kliniken), E. Bierhoff, Norbert H. Brockmeyer(Ruhr University Bochum), Judith Sirokay(University Hospital Bonn)
JDDG Journal der Deutschen Dermatologischen Gesellschaft
June 1, 2022
10.1111/ddg.14788
Cited by 21

Related Papers

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
|JAMA|2014|739
Germline mutations in BAP1 predispose to melanocytic tumors
|Nature Genetics|2011|724
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
|The Lancet Oncology|2016|704
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631